Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.

BGBC-354 is under clinical development by BeiGene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Sixteen-year-old Liz, from Harrogate, was diagnosed with desmoplastic small round cell tumour in January. Her mum, Vicky Roboyna, said doctors have told her daughter she has between six months and ...